Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: CYBERKEN who wrote (11831)	11/28/1997 3:54:00 AM
From: CYBERKEN	Read Replies (1) \| Respond to of 32384

Final thought on angiogenesis inhibitors: The future of cancer probably also contains earlier and more accurate diagnosis. That might lead to many cancer cases that would be eliminated by a drug like a rexiniod before the tumor has grown enough to begin angiogenesis. A friend of mine recently had a breast cancer tumor removed through a biopsy. Her doctor said the tumor was so small that he was surprised that they even detected it at that stage. Of course the possibility of cancer vaccines also exist that could limit the future market for all forms of treatments.